Biovision Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

Biovision Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 9, 2026	Diagonal Therapeutics	$125.0M Series B	Janus Henderson Investors, Paulina Hill	Atlas Venture, Balyasny Asset Management, BVF Partners, Checkpoint Capital, Deep Track Capital, EcoR1 Capital, Frazier Life Sciences, Lightspeed Venture Partners, Logos Capital, RA Capital Management, RV Invest, Velosity Capital, Viking Global Investors
May 1, 2024	Radar Therapeutics	$13.0M Seed	Omri Amirav-Drory	Angelic Ventures, Arizona Tech Investors, B Capital Group, Endeavor Venture Funds, ExSight Capital Management, IVP, NFX, Pioneer Fund, Prithvi Ventures, Chris Gibson, BEVC, Eli Lilly and Company, KdT Ventures, Pear VC
Jun 23, 2022	Elucid	$27.0M Series B	—	BlueStone Venture Partners, Bold Brain Ventures, IAG Capital Partners, John Fichthorn